Mayo Clinic Jacksonville - PPDS

Jacksonville, Florida 32224-1865

1 studies enrolling now · 12 studies all time

What they study most

Acute-graft-versus-host Disease, Advanced Solid Tumor, Breast Cancer, Cervical Cancer, Colorectal Cancer, Diffuse Large B Cell Lymphoma (DLBCL), Esophageal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastroesophageal Reflux Disease (GERD), Graft-versus-host Disease, Gynecologic Cancer

Studies at this site

• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now
• A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS) — Running, not enrolling
• A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies — Running, not enrolling
• Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) — Completed
• A Study of INCB059872 in Relapsed or Refractory Ewing Sarcoma — Stopped early
• A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery — Stopped early
• A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies — Completed
• A Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM) — Stopped early
• A Study of PY314 in Subjects With Advanced Solid Tumors — Stopped early
• Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy — Completed
• A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) — Stopped early
• An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD) — Completed